Articles tagged with "Janus Kinase Inhibitors"

Clinical Rheumatology Year in Review

November 22, 2021 • By Samantha C. Shapiro, MD

Case Report: A 5-Year-Old with an Ischemic Digit

September 14, 2021 • By Marta Michalska-Smith, MD, & Colleen K. Correll, MD, MPH

Janus Kinase Inhibitors Promising for Difficult-to-Treat RA

July 27, 2021 • By Michele B. Kaufman, PharmD, BCGP

Cytokine Targets & Treatment Developments for Psoriatic Arthritis & Spondyloarthritis

March 15, 2021 • By Carina Stanton

U.S. FDA Declines to Approve Eli Lilly & Incyte Arthritis Drug

April 17, 2017 • By Reuters Staff

U.S. & Europe Evaluate Abaloparatide Injection & Europe Approves Marketing Baricitinib for RA

April 11, 2017 • By Michele B. Kaufman, PharmD, BCGP

Baricitinib Is Effective in Patients Treated with DMARDs & Methotrexate

January 30, 2017 • By Lara C. Pullen, PhD

The OPAL Beyond Study: Tofacitinib Phase 3 Results Positive for Treating PsA

December 20, 2016 • By Michele B. Kaufman, PharmD, BCGP

Tofacitinib Shows Ongoing Action Against Plaque Psoriasis

March 3, 2016 • By David Douglas

New Research Points to Possible Future Treatment Option for Alopecia Areata

October 24, 2014 • By Lara C. Pullen, PhD